Early breast cancer.

No abstract is available for this paper.

• Publication year

  1970

• Venue

  British medical journal

• Publication date

  1970-06-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bmj.2.5711.735PMID 4914049PMCID PMC1700697
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current concepts in the primary treatment of operable carcinoma

  1969cited by this paper

• Marked Palliative Benefits Seen With Treatment of Very Advanced Breast Cancer With the Progesterone Receptor Modulator Mifepristone

  2026cites this paper
• Prognostic Value of Metabolic Parameters on Dedicated Breast Positron Emission Tomography in Luminal Breast Cancer

  2026cites this paper
• Plan Quality Variability in Radiotherapy of Whole Breast and Regional Lymph Nodes: An Intra-institutional Analysis

  2026cites this paper
• Sexual dysfunction in Brazilian women undergoing adjuvant endocrine therapy for breast cancer: prevalence and associated factors

  2026cites this paper
• Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy (SWEET): study protocol for a pragmatic randomised control trial of a patient-centred intervention to improve adherence to endocrine therapy in early breast cancer

  2025cites this paper
• Exploring the clinical value of regional nodal irradiation in sentinel lymph node positive breast cancer patients omitting axillary dissection

  2025cites this paper
• Implementing motivational interviewing to improve endocrine therapy adherence among breast cancer patients: a qualitative process evaluation of the getset pilot intervention

  2025influential citation
• Risk of endometrial cancer among breast cancer survivors in Japan: a matched cohort study

  2025cites this paper
• Optimizing Post-Neoadjuvant Treatment in Early Triple-Negative Breast Cancer

  2025influential citation
• T-DM1 with concurrent radiotherapy in HER2-positive breast cancer: preclinical evaluation and mechanisms, prediction, and exploration of adverse effects

  2025cites this paper
• Prognostic significance of receptor conversion following neoadjuvant therapy in breast cancer: a systematic review & meta-analysis

  2025cites this paper
• Addressing the Needs of Breast Cancer Survivors

  2025cites this paper
• Breast cancer treatment modalities, treatment delays, and survival in Brunei Darussalam

  2025cites this paper
• Androgen Receptors Promote Oxidative Phosphorylation and Resistance to Palmitate Lipotoxicity in ER-Mutant Breast Cancer

  2025cites this paper
• Utility score mapping from FACT-G to EQ-5D-5L and SF-6Dv2 in breast and colorectal cancer patients: a focus on beta mixture models

  2025cites this paper
• Decision Regret About Treatment Amongst Women With Early Breast Cancer: An Integrative Review

  2025influential citation
• Postmastectomy radiation therapy for autologous breast reconstruction: a systematic review and meta-analysis for the 2022 Japanese Breast Cancer Society Clinical Practice Guideline

  2025cites this paper
• 18F-FDG PET/CT radiomic analysis and artificial intelligence to predict pathological complete response after neoadjuvant chemotherapy in breast cancer patients

  2025cites this paper
• Use of routinely collected health data (England) to identify subsequent disease-related events in patients with primary breast cancer: a practical alternative to hospital-based follow-up for breast cancer clinical trials

  2025cites this paper
• Clinical–Genomic Risk Discordance in Early HR+/HER2− Breast Cancer: A Real-World Cohort from Japan Demonstrates Treatment Impact of Oncotype DX

  2025cites this paper
• The prognostic differences between breast-conserving surgery and mastectomy in patients with invasive ductal carcinoma who achieved complete response following neoadjuvant chemotherapy: a propensity score matched analysis based on the SEER database

  2025influential citation
• Adherence to adjuvant endocrine therapy including GnRH-analogues and survival: a population-based cohort study

  2025cites this paper
• Encoding Drug-Target-Pathway-Disease profiles for Drug-Cancer Association Prediction using Graph Transformer-Convolution Networks

  2025cites this paper
• Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy.

  2025cites this paper
• Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication model

  2025cites this paper
• Matching-adjusted indirect comparison of ribociclib + nonsteroidal aromatase inhibitor versus abemaciclib + endocrine therapy in hormone receptor-positive/HER2-negative early breast cancer

  2025cites this paper
• Predictive factors for breast conserving surgery after neoadjuvant chemotherapy in breast cancer

  2025cites this paper
• B1‐corrected breast T1 mapping at ultralow field

  2025cites this paper
• Timing of postmastectomy radiation therapy in two-stage expander/implant-based breast reconstruction: a systematic review and meta-analysis for the 2022 Japanese breast cancer society clinical practice guideline

  2025cites this paper
• Asian Society of Mastology-ASOMA Guide on Management of Early Breast Cancer

  2025cites this paper
• Neoadjuvant Chemotherapy for Early Breast Cancer: A Study on Response Rate and Toxicity

  2025cites this paper
• Cancer population norms using a new value set for the SF-6Dv2 based on the preferences of patients with breast or colorectal cancer in Quebec

  2024cites this paper
• Pilot randomized controlled trial of a program to enhance experience and adherence with adjuvant endocrine therapy among women with non-metastatic breast cancer: 12-month quantitative results

  2024cites this paper
• Advancing Breast Cancer Detection with Convolutional Neural Networks: A Comparative Analysis of MIAS and DDSM Datasets

  2024cites this paper
• Competing risk analysis of cardiovascular disease risk in breast cancer patients receiving a radiation boost

  2024cites this paper
• Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies

  2024cites this paper
• Anatomical assessment of local recurrence site in breast cancer patients after breast reconstruction and post-mastectomy radiotherapy: implications for radiation volumes and techniques

  2024cites this paper
• Modern radiotherapy for breast cancer: Update and new developments

  2024cites this paper
• Hypofractionated Partial Breast Irradiation With Intensity-Modulated Radiotherapy in Early Breast Cancer or Carcinoma In Situ: An Investigational Short-Term Analysis

  2024cites this paper
• Enhancing Breast Cancer Detection through Advanced Deep Learning: An Application of YOLOv8x on Mammographic Images

  2024cites this paper
• Initiation of Oral Endocrine Therapy and Survival Benefit Among Women with Early-Stage Breast Cancer

  2024cites this paper
• Circulating tumour cells predict recurrences and survival in head and neck squamous cell carcinoma patients

  2024cites this paper
• Enhancing clinical decision support with genomic tools in breast cancer: A Scottish perspective

  2024cites this paper
• A multifaceted role of bisphosphonates from palliative care to anti-cancer therapy in solid tumors

  2024cites this paper
• Radiation therapy volumes after primary systemic therapy in breast cancer patients: an international EUBREAST survey

  2024cites this paper
• The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study

  2024cites this paper
• Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up

  2024cites this paper
• The PI3K/AKT/mTOR signaling pathway in breast cancer: Review of clinical trials and latest advances

  2024cites this paper
• Addressing Residual Disease in HER2-Positive and Triple-Negative Breast Cancer: What Is Next?

  2024cites this paper
• A Randomised Controlled Trial Evaluating the Aesthetic Outcomes of Oncoplasty vs. Simple Closure and 1- vs. 2-cm Excision Margin for Early Breast Cancer

  2024cites this paper
• Shifting Paradigms in TNBC Treatment: Emerging Alternatives to Capecitabine in the Post-Neoadjuvant Setting

  2024cites this paper
• The Role of Adjuvant Radiotherapy in the Treatment of Breast Cancer

  2024cites this paper
• Return to Intended Oncological Therapy: State of the Art and Perspectives

  2024cites this paper
• Single-cell transcriptional analysis of irradiated skin reveals changes in fibroblast subpopulations and variability in caveolin expression

  2024cites this paper
• Ki-67 Change in Anthracyline-containing Neoadjuvant Chemotherapy Response in Breast Cancer

  2024cites this paper
• Comparison of radiological and histopathological features between interval and screen-detected breast cancers: a retrospective case–control study

  2024cites this paper
• The diagnostic value of multimodal imaging based on MR combined with ultrasound in benign and malignant breast diseases

  2024cites this paper
• Prevalence of Imaging Detected Silent Female Breast Cancer in Autopsy Specimens: Study of the Disease Held by Image-Guided Biopsies

  2024cites this paper
• SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)

  2023cites this paper
• Development and validation of a predictive nomogram for the specific mortality risk of luminal B breast cancer patients: a competing risk model based on real populations

  2023cites this paper
• Identification of Patients with Early HR+ HER2− Breast Cancer at High Risk of Recurrence

  2023cites this paper
• Pharmacogenetics and pharmacokinetics of tamoxifen in a Zimbabwean breast cancer cohort

  2023cites this paper
• Fully automated volumetric modulated arc therapy technique for radiation therapy of locally advanced breast cancer

  2023cites this paper
• Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey method

  2023cites this paper
• LAPTM5 regulated by FOXP3 promotes the malignant phenotypes of breast cancer through activating the Wnt/β‑catenin pathway

  2023cites this paper
• Molecular Aspects and Therapeutic Implications of Herbal Compounds Targeting Different Types of Cancer

  2023cites this paper
• Hsp70—A Universal Biomarker for Predicting Therapeutic Failure in Human Female Cancers and a Target for CTC Isolation in Advanced Cancers

  2023cites this paper
• Development and testing of a random forest-based machine learning model for predicting events among breast cancer patients with a poor response to neoadjuvant chemotherapy

  2023cites this paper
• Correlation of Beta2-Glycoprotein I With Tumor Prognosis in Breast Cancer Patients

  2023cites this paper
• Unpacking the surgical approach to nonpalpable breast lesions: bridging the knowledge gap between educators and trainees

  2023cites this paper
• Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor–Positive Metastatic Breast Cancer

  2023cites this paper
• A Universal Antigen-Ranking Method to Design Personalized Vaccines Targeting Neoantigens against Melanoma

  2023cites this paper
• Optimization of an Information Leaflet to Influence Medication Beliefs in Women With Breast Cancer: A Randomized Factorial Experiment

  2023cites this paper
• Morphology-Enhanced CAM-Guided SAM for weakly supervised Breast Lesion Segmentation

  2023cites this paper
• Hormone Treatment for Breast Cancer

  2023cites this paper
• NETWORK PHARMACOLOGY, APOPTOSIS, AND CELL CYCLE INHIBITION OF SESQUITERPENE COMPOUNDS FROM QUSTHUL HINDI ROOT EXTRACT (SAUSSUREA LAPPA) IN BREAST CANCER: AN IN SILICO AND IN VITRO APPROACH

  2023cites this paper
• Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens

  2023cites this paper
• Research Status of Systemic Adjuvant Therapy for Early Breast Cancer

  2023cites this paper
• Impact of Aerobic Training on Cardiovascular Function, Fitness, and Patient Reported Outcomes During Anthracycline Chemotherapy: A Case Series in Women With Breast Cancer

  2023cites this paper
• Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

  2023cites this paper
• Modern Radiotherapy and Cardiac Toxicity in Breast Cancer

  2023cites this paper
• Adherence to oral endocrine therapy in racial/ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic

  2023cites this paper
• The Prognostic and Predictive Value of Genomic Assays in Guiding Adjuvant Breast Radiation Therapy

  2022cites this paper
• Key concepts for informed health choices. 1.1: assumptions that treatments are safe or effective can be misleading

  2022cites this paper
• Variations in size-specific effective dose with patient stature and beam width for kV cone beam CT imaging in radiotherapy

  2022cites this paper
• Breast MRI Tumor Automatic Segmentation and Triple-Negative Breast Cancer Discrimination Algorithm Based on Deep Learning

  2022cites this paper
• New and Emerging Targeted Therapies for Advanced Breast Cancer

  2022cites this paper
• Evaluation of the quality and accuracy of breast cancer knowledge among persian language websites

  2022cites this paper
• A Novel TCGA-Validated, MiRNA-Based Signature for Prediction of Breast Cancer Prognosis and Survival

  2021cites this paper
• Effects of Wound Fluid on Breast Cancer-derived Spheroids in a 3D Culture System: A Case Series Study

  2021cites this paper
• Sentinel Node Biopsy After Neoadjuvant Chemotherapy In Breast Cancer: Real Life Results

  2021cites this paper
• Imidazo[1,2-a]pyridine Based Compounds: The Hopeful Anti-Cancer Therapy

  2021cites this paper
• Timeliness of diagnosis and treatment: the challenge of childhood cancers

  2021cites this paper
• Magnetically Guided Localization Using a Guiding-Marker System® and a Handheld Magnetic Probe for Nonpalpable Breast Lesions: A Multicenter Feasibility Study in Japan

  2021cites this paper
• ASIC1a promotes the proliferation of synovial fibroblasts via the ERK/MAPK pathway

  2021cites this paper
• Imidazo [ 1 , 2-a ] pyridineBasedCompounds : TheHopefulAnti-Cancer Therapy

  2021cites this paper
• Epigenetic modulators combination with chemotherapy in breast cancer cells

  2021cites this paper
• Classification techniques in breast cancer diagnosis: A systematic literature review

  2021cites this paper
• Breast cancer radiotherapy: What physicians need to know in the era of the precision medicine

  2021cites this paper
• Elevated EXO1 expression is associated with breast carcinogenesis and poor prognosis

  2021cites this paper